Your search returned 5 results.

Results
	1.	Two-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole. [electronic resource] by Patel, Chirag G Li, Li Girgis, Suzette Kornhauser, David M Frevert, Ernest U Boulton, David W Producer: 20120823 In: Clinical pharmacology : advances and applications vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Influence of renal or hepatic impairment on the pharmacokinetics of saxagliptin. [electronic resource] by Boulton, David W Li, Li Frevert, Ernst U Tang, Angela Castaneda, Lorna Vachharajani, Nimish N Kornhauser, David M Patel, Chirag G Producer: 20110620 In: Clinical pharmacokinetics vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Safety, tolerability, pharmacokinetics, and time course of pharmacologic response of the active metabolite of roxifiban, XV459, a glycoprotein IIb/IIIa antagonist, following oral administration in healthy volunteers. [electronic resource] by Pieniaszek, Henry J Sy, Sherwin K B Ebling, William Fossler, Michael J Cain, Valerie A Mondick, John T Ma, Su Kornhauser, David M Producer: 20030210 In: Journal of clinical pharmacology vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonist. [electronic resource] by Seiffert, Dietmar Thomas, Beth E Bradley, Jodi D Munzer, Deborah A Tchinnes, Maureen A Kornhauser, David M Cain, Valerie A Hua, Tsuhung A Feuerstein, Giora Z Martin, David E Stern, Andrew M Producer: 20040227 In: Platelets vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder. [electronic resource] by Findling, Robert L Kauffman, Ralph Sallee, Floyd R Salazar, Daniel E Sahasrabudhe, Vaishali Kollia, Georgia Kornhauser, David M Vachharajani, Nimish N Assuncao-Talbott, Sheila Mallikaarjun, Suresh Iwamoto, Taro McQuade, Robert D Boulton, David W Blumer, Jeffrey Producer: 20100121 In: Journal of child and adolescent psychopharmacology vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)